Advertisement

Tislelizumab Plus Chemotherapy for Recurrent/Metastatic Nasopharyngeal Cancer: RATIONALE-309
Posted: 05/04/2022 | By: Sarah Campen, PharmD

Question 1 of 5

What kind of agent is tislelizumab?

Choose 1

A
Recombinant human immunoglobulin G1 monoclonal antibody that binds to VEGFR-2
B
Humanized immunoglobulin G4 monoclonal antibody that binds to PD-1
C
Chimeric monoclonal antibody that binds to EGFR
D
Human monoclonal antibody that binds to the cytokine RANKL

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage